In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Preclinical Efficacy
Instem Team
Enhancing Study Quality and Data Integrity in the Preclinical Phase
In Silico & Data Insights Blog
In Silico & Data InsightsLeadscopePress Releases
INSTEM Announces Extension of Research Collaboration Agreement with U.S. FDA to 2031
Mike Thurogood, CMktr
Instem, a global leader in SaaS solutions for life sciences R&D, today announced a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA).
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Lead Optimization
Instem Team
Unifying Science and Safety to Navigate the Iterative Path of Lead Optimization
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Discovery
Instem Team
Discover how Instem’s Advance™, Predict™, and BioRails® accelerate early-stage drug discovery by unifying in silico insights, experimental data, and streamlined workflows.
In Silico & Data InsightsRegulatory SubmissionStudy Management
The Journey of a Molecule – Target Identification
Instem Team
With integrated, insight‑driven platforms that cut through data complexity and eliminate fragmented workflows, Instem empowers researchers to reduce risk, boost efficiency, and accelerate the journey from discovery to IND submission.
In Silico & Data InsightsLeadscopeRegulatory Submission
My Thoughts on NAMs and the Future of Drug Development: Progress Demands Leadership
Instem Team
NAMs have the potential to deliver more efficient safety assessments, enabling faster and more confident development decisions while also supporting more ethical drug development.
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.
